Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas
Predicting the behavior of meningiomas based on histopathologic features alone has remained problematic. This study retrospectively compared several histopathologic features and MIB-1 labeling indices (LIs) in recurrent meningiomas with those of nonrecurrent meningiomas. Six histopathologic features...
Saved in:
Published in | Archives of pathology & laboratory medicine (1976) Vol. 123; no. 9; pp. 793 - 800 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
College of American Pathologists
01.09.1999
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Predicting the behavior of meningiomas based on histopathologic features alone has remained problematic.
This study retrospectively compared several histopathologic features and MIB-1 labeling indices (LIs) in recurrent meningiomas with those of nonrecurrent meningiomas. Six histopathologic features, including mitoses, necrosis, loss of architectural pattern, hypervascularity/hemosiderin deposition, prominent nucleoli, and nuclear pleomorphism, were compared between 32 recurrent and 27 nonrecurrent meningiomas using Fisher exact tests. MIB-1 LIs (% positive tumor cell nuclei) were compared using the Wilcoxon rank sum test.
The patients in the recurrent group included 26 women (mean age, 55 years), who developed 1 to 5 recurrences. Time intervals to the first recurrence ranged from 5 to 183 months (mean, 55 months). The nonrecurrent group included 21 women (mean age, 56 years), with follow-up ranging from 88 to 124 months (mean, 109 months). Of the histopathologic features evaluated, statistically significant differences between the recurrent and nonrecurrent groups were found only with respect to prominent nucleoli (P =.024) and nuclear pleomorphism (P <.001), both of which were more common in the recurrent group. In the recurrent group, 9 tumors were considered malignant (defined by brain invasion or metastasis) versus 2 of the nonrecurrent meningiomas. Nineteen percent of nonrecurrent tumors versus 41% of recurrent tumors had 2 or more of the 6 histopathologic features. MIB-1 LIs in the nonrecurrent group ranged from 0 to 8.3 (mean, 1.5) and were generally lower than those in the recurrent group (range, 0-32.5; mean, 5.4); no statistical difference was identified between these groups. No statistically significant difference with regard to histology or MIB-1 LIs was noted between the initially excised recurrent tumor and the most recently resected recurrence.
Of the histopathologic features examined, only prominent nucleoli and nuclear pleomorphism were found to be statistically more common in recurrent than nonrecurrent meningiomas. The mean MIB-1 LI was higher in the recurrent than in the nonrecurrent group, although there was no statistical difference between means and there was clear overlap with regard to MIB-1 LI ranges. |
---|---|
AbstractList | Predicting the behavior of meningiomas based on histopathologic features alone has remained problematic.
This study retrospectively compared several histopathologic features and MIB-1 labeling indices (LIs) in recurrent meningiomas with those of nonrecurrent meningiomas. Six histopathologic features, including mitoses, necrosis, loss of architectural pattern, hypervascularity/hemosiderin deposition, prominent nucleoli, and nuclear pleomorphism, were compared between 32 recurrent and 27 nonrecurrent meningiomas using Fisher exact tests. MIB-1 LIs (% positive tumor cell nuclei) were compared using the Wilcoxon rank sum test.
The patients in the recurrent group included 26 women (mean age, 55 years), who developed 1 to 5 recurrences. Time intervals to the first recurrence ranged from 5 to 183 months (mean, 55 months). The nonrecurrent group included 21 women (mean age, 56 years), with follow-up ranging from 88 to 124 months (mean, 109 months). Of the histopathologic features evaluated, statistically significant differences between the recurrent and nonrecurrent groups were found only with respect to prominent nucleoli (P =.024) and nuclear pleomorphism (P <.001), both of which were more common in the recurrent group. In the recurrent group, 9 tumors were considered malignant (defined by brain invasion or metastasis) versus 2 of the nonrecurrent meningiomas. Nineteen percent of nonrecurrent tumors versus 41% of recurrent tumors had 2 or more of the 6 histopathologic features. MIB-1 LIs in the nonrecurrent group ranged from 0 to 8.3 (mean, 1.5) and were generally lower than those in the recurrent group (range, 0-32.5; mean, 5.4); no statistical difference was identified between these groups. No statistically significant difference with regard to histology or MIB-1 LIs was noted between the initially excised recurrent tumor and the most recently resected recurrence.
Of the histopathologic features examined, only prominent nucleoli and nuclear pleomorphism were found to be statistically more common in recurrent than nonrecurrent meningiomas. The mean MIB-1 LI was higher in the recurrent than in the nonrecurrent group, although there was no statistical difference between means and there was clear overlap with regard to MIB-1 LI ranges. Predicting the behavior of meningiomas based on histopathologic features alone has remained problematic. This study retrospectively compared several histopathologic features and MIB-1 labeling indices (LIs) in recurrent meningiomas with those of nonrecurrent meningiomas. Six histopathologic features, including mitoses, necrosis, loss of architectural pattern, hypervascularity/hemosiderin deposition, prominent nucleoli, and nuclear pleomorphism, were compared between 32 recurrent and 27 nonrecurrent meningiomas using Fisher exact tests. MIB-1 LIs (% positive tumor cell nuclei) were compared using the Wilcoxon rank sum test. The patients in the recurrent group included 26 women (mean age, 55 years), who developed 1 to 5 recurrences. Time intervals to the first recurrence ranged from 5 to 183 months (mean, 55 months). The nonrecurrent group included 21 women (mean age, 56 years), with follow-up ranging from 88 to 124 months (mean, 109 months). Of the histopathologic features evaluated, statistically significant differences between the recurrent and nonrecurrent groups were found only with respect to prominent nucleoli (P =.024) and nuclear pleomorphism (P <.001), both of which were more common in the recurrent group. In the recurrent group, 9 tumors were considered malignant (defined by brain invasion or metastasis) versus 2 of the nonrecurrent meningiomas. Nineteen percent of nonrecurrent tumors versus 41% of recurrent tumors had 2 or more of the 6 histopathologic features. MIB-1 LIs in the nonrecurrent group ranged from 0 to 8.3 (mean, 1.5) and were generally lower than those in the recurrent group (range, 0-32.5; mean, 5.4); no statistical difference was identified between these groups. No statistically significant difference with regard to histology or MIB-1 LIs was noted between the initially excised recurrent tumor and the most recently resected recurrence. Of the histopathologic features examined, only prominent nucleoli and nuclear pleomorphism were found to be statistically more common in recurrent than nonrecurrent meningiomas. The mean MIB-1 LI was higher in the recurrent than in the nonrecurrent group, although there was no statistical difference between means and there was clear overlap with regard to MIB-1 LI ranges. Abstract Background.—Predicting the behavior of meningiomas based on histopathologic features alone has remained problematic. Design.—This study retrospectively compared several histopathologic features and MIB-1 labeling indices (LIs) in recurrent meningiomas with those of nonrecurrent meningiomas. Six histopathologic features, including mitoses, necrosis, loss of architectural pattern, hypervascularity/hemosiderin deposition, prominent nucleoli, and nuclear pleomorphism, were compared between 32 recurrent and 27 nonrecurrent meningiomas using Fisher exact tests. MIB-1 LIs (% positive tumor cell nuclei) were compared using the Wilcoxon rank sum test. Results.—The patients in the recurrent group included 26 women (mean age, 55 years), who developed 1 to 5 recurrences. Time intervals to the first recurrence ranged from 5 to 183 months (mean, 55 months). The nonrecurrent group included 21 women (mean age, 56 years), with follow-up ranging from 88 to 124 months (mean, 109 months). Of the histopathologic features evaluated, statistically significant differences between the recurrent and nonrecurrent groups were found only with respect to prominent nucleoli (P = .024) and nuclear pleomorphism (P < .001), both of which were more common in the recurrent group. In the recurrent group, 9 tumors were considered malignant (defined by brain invasion or metastasis) versus 2 of the nonrecurrent meningiomas. Nineteen percent of nonrecurrent tumors versus 41% of recurrent tumors had 2 or more of the 6 histopathologic features. MIB-1 LIs in the nonrecurrent group ranged from 0 to 8.3 (mean, 1.5) and were generally lower than those in the recurrent group (range, 0–32.5; mean, 5.4); no statistical difference was identified between these groups. No statistically significant difference with regard to histology or MIB-1 LIs was noted between the initially excised recurrent tumor and the most recently resected recurrence. Conclusions.—Of the histopathologic features examined, only prominent nucleoli and nuclear pleomorphism were found to be statistically more common in recurrent than nonrecurrent meningiomas. The mean MIB-1 LI was higher in the recurrent than in the nonrecurrent group, although there was no statistical difference between means and there was clear overlap with regard to MIB-1 LI ranges. |
Author | Prayson, R A Abramovich, C M |
Author_xml | – sequence: 1 givenname: C M surname: Abramovich fullname: Abramovich, C M organization: Department of Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA – sequence: 2 givenname: R A surname: Prayson fullname: Prayson, R A |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/10458826$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkMlOwzAQhi1URBd4A4Qi7gbbiVP7WCpKK7XiAkdkOV6Kq8QpdnLg7XFJJbjMaGb-2b4pGPnWGwBuMXqgjLJHzDmHmOQQzXkO16vFbru5ABNMixwSXNIRmCCEcsg5o2MwjfGQQk4IvgJjjArKGCkn4GPtYtceZffZ1u3eqcwa2fXBxEx6ne02TxBntaxM7fw-c147lUrOZ8GoPgTju19dOu0v0RifxK5tZLwGl1bW0dyc_Qy8r57flmu4fX3ZLBdbqAjnHbTIcskKJivCbSVZrhXGlVVzW1FlGJOlplqWtkwf4IIkS7DJEVWlrphWMp-B-2HuMbRfvYmdOLR98GmlIBjzkiM2T6JiEKnQxhiMFcfgGhm-BUbihFSckIqEVJyQigFpars7z-6rxuh_TQPD_AddCnWL |
CODEN | APLMAS |
CitedBy_id | crossref_primary_10_1002_1097_0142_20000901_89_5_1102__AID_CNCR20_3_0_CO_2_L crossref_primary_10_3889_oamjms_2019_032 crossref_primary_10_1097_01_pap_0000163957_21409_52 crossref_primary_10_1016_j_jocn_2010_10_020 crossref_primary_10_1309_W0H705HAJL73T0EQ crossref_primary_10_1016_j_wneu_2018_08_084 crossref_primary_10_1080_02688697_2019_1638886 crossref_primary_10_1097_PAI_0b013e318289f490 crossref_primary_10_3390_cancers16091753 crossref_primary_10_1002_ijc_11013 crossref_primary_10_1007_s00428_006_0285_3 crossref_primary_10_1016_S0161_6420_03_00787_5 crossref_primary_10_1093_ajcp_aqw141 crossref_primary_10_1097_00000478_200104000_00006 crossref_primary_10_1292_jvms_21_0258 crossref_primary_10_1016_j_clineuro_2020_105897 crossref_primary_10_1016_j_prp_2010_09_002 crossref_primary_10_1097_DAD_0000000000001019 crossref_primary_10_1007_s00586_005_0937_z crossref_primary_10_1016_j_surneu_2005_02_006 crossref_primary_10_1097_00000478_200301000_00015 crossref_primary_10_1002_1097_0142_20011115_92_10_2720__AID_CNCR1626_3_0_CO_2_Z crossref_primary_10_3171_2016_10_JNS161825 crossref_primary_10_5858_2002_126_1079_DTIACA crossref_primary_10_1016_j_jocn_2007_12_005 crossref_primary_10_1016_j_ajoms_2011_02_006 crossref_primary_10_1111_j_1440_1789_2007_00801_x crossref_primary_10_1007_s00701_016_2900_7 crossref_primary_10_1002_cncr_22130 crossref_primary_10_1007_s00701_012_1273_9 crossref_primary_10_1111_j_1365_2184_2005_00325_x crossref_primary_10_1267_ahc_38_9 crossref_primary_10_1177_030089160809400316 crossref_primary_10_5858_2005_129_e173_AYWWDI crossref_primary_10_1093_jnen_61_8_663 crossref_primary_10_1002_cyto_b_21202 crossref_primary_10_1007_s11060_005_9078_9 crossref_primary_10_1371_journal_pone_0037379 crossref_primary_10_1002_cncr_10351 crossref_primary_10_1007_s12149_013_0747_z crossref_primary_10_1354_vp_08_VP_0185_M_FL |
Cites_doi | 10.1002/1097-0142(19861001)58:7<1466::AID-CNCR2820580715>3.0.CO;2-W 10.1016/S1042-3680(18)30526-6 10.1111/j.1750-3639.1993.tb00752.x 10.1093/ajcp/106.6.776 10.3171/jns.1992.77.4.0616 10.1007/s004010050458 10.3171/jns.1983.58.1.0051 10.1007/BF00312803 10.1002/1097-0142(19941215)74:12<3176::AID-CNCR2820741217>3.0.CO;2-N 10.1227/00006123-199509000-00016 10.1007/BF00386253 10.55418/9781933477015 10.1016/0090-3019(86)90259-4 10.1093/ajcp/105.6.719 10.1016/S0046-8177(98)90224-6 10.1002/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.0.CO;2-R 10.1007/BF00294650 10.1097/00000478-199712000-00008 10.1097/00000478-199303000-00004 10.1002/1097-0142(19930101)71:1<199::AID-CNCR2820710131>3.0.CO;2-S 10.1136/jnnp.20.1.22 10.1007/BF02187190 10.3171/jns.1997.86.5.0793 10.1097/00000478-198612000-00002 10.1097/00005072-199405000-00005 10.1227/00006123-199512000-00003 10.1007/BF00688260 10.1016/0090-3019(85)90180-6 10.1016/S0344-0338(96)80055-0 10.1002/(SICI)1097-0142(19960701)78:1<133::AID-CNCR19>3.0.CO;2-0 10.1016/S0046-8177(96)90107-0 10.1023/A:1005794700267 10.1111/j.1365-2559.1993.tb01218.x 10.1016/0090-3019(86)90081-9 |
ContentType | Journal Article |
Copyright | Copyright College of American Pathologists Sep 1999 |
Copyright_xml | – notice: Copyright College of American Pathologists Sep 1999 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 4T- 4U- 7RV 7X7 7XB 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M2P M7P NAPCQ PQEST PQQKQ PQUKI PRINS Q9U |
DOI | 10.5858/1999-123-0793-HFAMLI |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Docstoc University Readers Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Health & Medical Collection (Alumni Edition) Medical Database Science Database Biological Science Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef University Readers ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Docstoc ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE University Readers CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1543-2165 |
EndPage | 800 |
ExternalDocumentID | 44378631 10_5858_1999_123_0793_HFAMLI 10458826 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- -~X .55 .GJ 04C 1CY 23N 2WC 36B 3O- 3V. 53G 5GY 5RE 6PF 7RV 7X7 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8R4 8R5 AAQOH AAQQT AAWTL ABCQX ABDBF ABOCM ABUWG ACGFO ACGOD ACPRK ADBBV ADOJX AENEX AFFNX AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC B0M BAWUL BBNVY BENPR BHPHI BKEYQ BKOMP BMSDO BPHCQ BVXVI C1A CCPQU CGR CUY CVF DIK DWQXO E3Z EAP EAS EBC EBD EBS ECF ECM ECT ECV EHN EIF EIHBH EJD EMB EMK EMOBN ENC EPL EPT ESX EX3 F5P FAC FAL FJD FJW FRP FYUFA GNUQQ GX1 HCIFZ HMCUK IAO IEA IHR IHW INH INR IOF ITC J5H L7B LK8 M1P M2P M2Q M7P NAPCQ NPM OK1 P2P PCD PQQKQ PROAC PSQYO PV9 Q2X Q~Q RWL RXW RZL SV3 TAE TAF TR2 TUS TWZ UDS UKHRP W2D WH7 WOW WQ9 X6Y X7M Y3D YQJ ZGI ZXP ~8M AAYXX CITATION 4T- 4U- 7XB 8FK K9. PQEST PQUKI PRINS Q9U |
ID | FETCH-LOGICAL-c299t-f0f9a848ab29fba83dc11bfc7fb5ce88a6d5da6f600014200021e305c6db8dca3 |
IEDL.DBID | 7X7 |
ISSN | 0003-9985 |
IngestDate | Fri Sep 13 07:19:55 EDT 2024 Fri Aug 23 01:49:20 EDT 2024 Sat Sep 28 07:35:27 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c299t-f0f9a848ab29fba83dc11bfc7fb5ce88a6d5da6f600014200021e305c6db8dca3 |
PMID | 10458826 |
PQID | 211969087 |
PQPubID | 42082 |
PageCount | 8 |
ParticipantIDs | proquest_journals_211969087 crossref_primary_10_5858_1999_123_0793_HFAMLI pubmed_primary_10458826 |
PublicationCentury | 1900 |
PublicationDate | 1999-09-01 |
PublicationDateYYYYMMDD | 1999-09-01 |
PublicationDate_xml | – month: 09 year: 1999 text: 1999-09-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Northfield |
PublicationTitle | Archives of pathology & laboratory medicine (1976) |
PublicationTitleAlternate | Arch Pathol Lab Med |
PublicationYear | 1999 |
Publisher | College of American Pathologists |
Publisher_xml | – name: College of American Pathologists |
References | de la Monte (2021012823245620300_i1543-2165-123-8-15-b6) 1986; 10 Goldblum (2021012823245620300_i1543-2165-123-8-15-b39) 1993; 6 Moller (2021012823245620300_i1543-2165-123-8-15-b29) 1997; 34 Adegbite (2021012823245620300_i1543-2165-123-8-15-b2) 1983; 58 McLean (2021012823245620300_i1543-2165-123-8-15-b12) 1993; 23 Lee (2021012823245620300_i1543-2165-123-8-15-b25) 1990; 80 Hoshino (2021012823245620300_i1543-2165-123-8-15-b18) 1986; 58 Burger (2021012823245620300_i1543-2165-123-8-15-b17) Perry (2021012823245620300_i1543-2165-123-8-15-b1) 1997; 21 Maier (2021012823245620300_i1543-2165-123-8-15-b11) 1992; 77 Miller (2021012823245620300_i1543-2165-123-8-15-b15) 1994; 5 Jellinger (2021012823245620300_i1543-2165-123-8-15-b8) 1975; 208 Perry (2021012823245620300_i1543-2165-123-8-15-b33) 1998; 82 Matsuno (2021012823245620300_i1543-2165-123-8-15-b26) 1996; 91 Simpson (2021012823245620300_i1543-2165-123-8-15-b4) 1957; 20 Salmon (2021012823245620300_i1543-2165-123-8-15-b35) 1993; 17 Madsen (2021012823245620300_i1543-2165-123-8-15-b28) 1997; 16(3) Matsuno (2021012823245620300_i1543-2165-123-8-15-b27) 1996; 106 Ide (2021012823245620300_i1543-2165-123-8-15-b20) 1996; 78 Karamitopoulou (2021012823245620300_i1543-2165-123-8-15-b21) 1994; 87 Kolles (2021012823245620300_i1543-2165-123-8-15-b23) 1995; 137 Marks (2021012823245620300_i1543-2165-123-8-15-b3) 1986; 25 Roggendorf (2021012823245620300_i1543-2165-123-8-15-b34) 1987; 73 Striepecke (2021012823245620300_i1543-2165-123-8-15-b38) 1996; 192 Palma (2021012823245620300_i1543-2165-123-8-15-b14) 1997; 86 Langford (2021012823245620300_i1543-2165-123-8-15-b24) 1996; 27 Shibuya (2021012823245620300_i1543-2165-123-8-15-b37) 1993; 71 Tubbs (2021012823245620300_i1543-2165-123-8-15-b40) 1984; 1 Kleihues (2021012823245620300_i1543-2165-123-8-15-b9) 1993; 3 Niedermayer (2021012823245620300_i1543-2165-123-8-15-b13) 1996; 15 Nakasu (2021012823245620300_i1543-2165-123-8-15-b31) 1995; 37 Jääskeläinen (2021012823245620300_i1543-2165-123-8-15-b5) 1986; 26 Jääskeläinen (2021012823245620300_i1543-2165-123-8-15-b7) 1985; 24 Karamitopoulou (2021012823245620300_i1543-2165-123-8-15-b22) 1998; 29 Ohta (2021012823245620300_i1543-2165-123-8-15-b32) 1994; 74 Shibuya (2021012823245620300_i1543-2165-123-8-15-b36) 1992; 30 Hsu (2021012823245620300_i1543-2165-123-8-15-b19) 1994; 53 Prayson (2021012823245620300_i1543-2165-123-8-15-b16) 1996; 105 Mahmood (2021012823245620300_i1543-2165-123-8-15-b10) 1993; 33 Nagashima (2021012823245620300_i1543-2165-123-8-15-b30) 1995; 37 |
References_xml | – volume: 58 start-page: 1466 year: 1986 ident: 2021012823245620300_i1543-2165-123-8-15-b18 article-title: Proliferative potential of human meningiomas of the brain: a cell kinetics study with bromodeoxyuridine. publication-title: Cancer doi: 10.1002/1097-0142(19861001)58:7<1466::AID-CNCR2820580715>3.0.CO;2-W contributor: fullname: Hoshino – volume: 5 start-page: 193 year: 1994 ident: 2021012823245620300_i1543-2165-123-8-15-b15 article-title: Predicting recurrence of intracranial meningiomas: a multivariate clinical pathologic model: interim report of the New York University Medical Center meningioma project. publication-title: Neurosurg Clin North Am doi: 10.1016/S1042-3680(18)30526-6 contributor: fullname: Miller – volume: 16(3) start-page: 137 year: 1997 ident: 2021012823245620300_i1543-2165-123-8-15-b28 article-title: Ki-67 immunoreactivity in meningiomas: determination of the proliferative potential of meningiomas using the monoclonal antibody Ki-67. publication-title: Clin Neuropathol contributor: fullname: Madsen – volume: 3 start-page: 255 year: 1993 ident: 2021012823245620300_i1543-2165-123-8-15-b9 article-title: The new WHO classification of brain tumours. publication-title: Brain Pathol doi: 10.1111/j.1750-3639.1993.tb00752.x contributor: fullname: Kleihues – volume: 106 start-page: 776 year: 1996 ident: 2021012823245620300_i1543-2165-123-8-15-b27 article-title: Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. publication-title: Am J Clin Pathol doi: 10.1093/ajcp/106.6.776 contributor: fullname: Matsuno – volume: 77 start-page: 616 year: 1992 ident: 2021012823245620300_i1543-2165-123-8-15-b11 article-title: Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. publication-title: J Neurosurg doi: 10.3171/jns.1992.77.4.0616 contributor: fullname: Maier – volume: 91 start-page: 504 year: 1996 ident: 2021012823245620300_i1543-2165-123-8-15-b26 article-title: Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. publication-title: Acta Neuropathol doi: 10.1007/s004010050458 contributor: fullname: Matsuno – volume: 58 start-page: 51 year: 1983 ident: 2021012823245620300_i1543-2165-123-8-15-b2 article-title: The recurrence of intracranial meningiomas after surgical treatment. publication-title: J Neurosurg doi: 10.3171/jns.1983.58.1.0051 contributor: fullname: Adegbite – volume: 208 start-page: 279 year: 1975 ident: 2021012823245620300_i1543-2165-123-8-15-b8 article-title: Histological subtypes and prognostic problems in meningiomas. publication-title: J Neurol doi: 10.1007/BF00312803 contributor: fullname: Jellinger – volume: 30 start-page: 494 year: 1992 ident: 2021012823245620300_i1543-2165-123-8-15-b36 article-title: Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. publication-title: Neurosurgery contributor: fullname: Shibuya – volume: 74 start-page: 3176 year: 1994 ident: 2021012823245620300_i1543-2165-123-8-15-b32 article-title: MIB1 staining index and scoring of histologic features in meningiomas: indicators for the prediction of biologic potential and postoperative management. publication-title: Cancer doi: 10.1002/1097-0142(19941215)74:12<3176::AID-CNCR2820741217>3.0.CO;2-N contributor: fullname: Ohta – volume: 37 start-page: 478 year: 1995 ident: 2021012823245620300_i1543-2165-123-8-15-b30 article-title: Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. publication-title: Neurosurgery doi: 10.1227/00006123-199509000-00016 contributor: fullname: Nagashima – volume: 87 start-page: 47 year: 1994 ident: 2021012823245620300_i1543-2165-123-8-15-b21 article-title: Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB-1 monoclonal antibody on archival material. publication-title: Acta Neuropathol doi: 10.1007/BF00386253 contributor: fullname: Karamitopoulou – ident: 2021012823245620300_i1543-2165-123-8-15-b17 article-title: Tumors of the Central Nervous System. doi: 10.55418/9781933477015 contributor: fullname: Burger – volume: 26 start-page: 461 year: 1986 ident: 2021012823245620300_i1543-2165-123-8-15-b5 article-title: Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. publication-title: Surg Neurol doi: 10.1016/0090-3019(86)90259-4 contributor: fullname: Jääskeläinen – volume: 105 start-page: 719 year: 1996 ident: 2021012823245620300_i1543-2165-123-8-15-b16 article-title: Malignant meningioma: a clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry. publication-title: Am J Clin Pathol doi: 10.1093/ajcp/105.6.719 contributor: fullname: Prayson – volume: 29 start-page: 140 year: 1998 ident: 2021012823245620300_i1543-2165-123-8-15-b22 article-title: Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. publication-title: Hum Pathol doi: 10.1016/S0046-8177(98)90224-6 contributor: fullname: Karamitopoulou – volume: 82 start-page: 2262 year: 1998 ident: 2021012823245620300_i1543-2165-123-8-15-b33 article-title: The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.0.CO;2-R contributor: fullname: Perry – volume: 80 start-page: 311 year: 1990 ident: 2021012823245620300_i1543-2165-123-8-15-b25 article-title: Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. publication-title: Acta Neuropathol doi: 10.1007/BF00294650 contributor: fullname: Lee – volume: 21 start-page: 1455 year: 1997 ident: 2021012823245620300_i1543-2165-123-8-15-b1 article-title: Meningioma grading: an analysis of histologic parameters. publication-title: Am J Surg Pathol doi: 10.1097/00000478-199712000-00008 contributor: fullname: Perry – volume: 17 start-page: 239 year: 1993 ident: 2021012823245620300_i1543-2165-123-8-15-b35 article-title: Characterization of nuclear DNA content, proliferation index, and nuclear size in a series of 181 meningiomas, including benign primary, recurrent, and malignant tumors. publication-title: Am J Surg Pathol doi: 10.1097/00000478-199303000-00004 contributor: fullname: Salmon – volume: 71 start-page: 199 year: 1993 ident: 2021012823245620300_i1543-2165-123-8-15-b37 article-title: Proliferative potential of brain tumors: analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. publication-title: Cancer doi: 10.1002/1097-0142(19930101)71:1<199::AID-CNCR2820710131>3.0.CO;2-S contributor: fullname: Shibuya – volume: 20 start-page: 22 year: 1957 ident: 2021012823245620300_i1543-2165-123-8-15-b4 article-title: The recurrence of intracranial meningiomas after surgical treatment. publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.20.1.22 contributor: fullname: Simpson – volume: 6 start-page: 663 year: 1993 ident: 2021012823245620300_i1543-2165-123-8-15-b39 article-title: Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. publication-title: Mod Pathol contributor: fullname: Goldblum – volume: 137 start-page: 174 year: 1995 ident: 2021012823245620300_i1543-2165-123-8-15-b23 article-title: Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. publication-title: Acta Neurochir doi: 10.1007/BF02187190 contributor: fullname: Kolles – volume: 86 start-page: 793 year: 1997 ident: 2021012823245620300_i1543-2165-123-8-15-b14 article-title: Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. publication-title: J Neurosurg doi: 10.3171/jns.1997.86.5.0793 contributor: fullname: Palma – volume: 10 start-page: 836 year: 1986 ident: 2021012823245620300_i1543-2165-123-8-15-b6 article-title: Histopathologic features predicting recurrence of meningiomas following subtotal resection. publication-title: Am J Surg Pathol doi: 10.1097/00000478-198612000-00002 contributor: fullname: de la Monte – volume: 53 start-page: 247 year: 1994 ident: 2021012823245620300_i1543-2165-123-8-15-b19 article-title: Prognostic significance of proliferative indices in meningiomas. publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-199405000-00005 contributor: fullname: Hsu – volume: 37 start-page: 1049 year: 1995 ident: 2021012823245620300_i1543-2165-123-8-15-b31 article-title: Meningioma: proliferating potential and clinicoradiological features. publication-title: Neurosurgery doi: 10.1227/00006123-199512000-00003 contributor: fullname: Nakasu – volume: 73 start-page: 361 year: 1987 ident: 2021012823245620300_i1543-2165-123-8-15-b34 article-title: Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. publication-title: Acta Neuropathol doi: 10.1007/BF00688260 contributor: fullname: Roggendorf – volume: 24 start-page: 165 year: 1985 ident: 2021012823245620300_i1543-2165-123-8-15-b7 article-title: The growth rate of intracranial meningiomas and its relation to histology. publication-title: Surg Neurol doi: 10.1016/0090-3019(85)90180-6 contributor: fullname: Jääskeläinen – volume: 15 start-page: 330 year: 1996 ident: 2021012823245620300_i1543-2165-123-8-15-b13 article-title: Characterization of intermediate type (“WHO atypical”) meningiomas. publication-title: Clin Neuropathol contributor: fullname: Niedermayer – volume: 192 start-page: 816 year: 1996 ident: 2021012823245620300_i1543-2165-123-8-15-b38 article-title: Correlation of histology, cytogenetics, and proliferation fraction (Ki-67 and PCNA) quantitated by image analysis in meningiomas. publication-title: Pathol Res Pract doi: 10.1016/S0344-0338(96)80055-0 contributor: fullname: Striepecke – volume: 33 start-page: 955 year: 1993 ident: 2021012823245620300_i1543-2165-123-8-15-b10 article-title: Atypical and malignant meningiomas: a clinicopathological review. publication-title: Neurosurgery contributor: fullname: Mahmood – volume: 78 start-page: 133 year: 1996 ident: 2021012823245620300_i1543-2165-123-8-15-b20 article-title: MIB-1 staining index and peritumoral brain edema of meningiomas. publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19960701)78:1<133::AID-CNCR19>3.0.CO;2-0 contributor: fullname: Ide – volume: 27 start-page: 350 year: 1996 ident: 2021012823245620300_i1543-2165-123-8-15-b24 article-title: Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. publication-title: Hum Pathol doi: 10.1016/S0046-8177(96)90107-0 contributor: fullname: Langford – volume: 34 start-page: 241 year: 1997 ident: 2021012823245620300_i1543-2165-123-8-15-b29 article-title: No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry. publication-title: J Neurooncol doi: 10.1023/A:1005794700267 contributor: fullname: Moller – volume: 23 start-page: 349 year: 1993 ident: 2021012823245620300_i1543-2165-123-8-15-b12 article-title: Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. publication-title: Histopathology doi: 10.1111/j.1365-2559.1993.tb01218.x contributor: fullname: McLean – volume: 25 start-page: 436 year: 1986 ident: 2021012823245620300_i1543-2165-123-8-15-b3 article-title: Recurrence of meningiomas after operation. publication-title: Surg Neurol doi: 10.1016/0090-3019(86)90081-9 contributor: fullname: Marks – volume: 1 start-page: 272 year: 1984 ident: 2021012823245620300_i1543-2165-123-8-15-b40 article-title: Immunohistology of lymphoproliferative disorders. publication-title: Semin Diagn Pathol contributor: fullname: Tubbs |
SSID | ssj0009221 |
Score | 1.875148 |
Snippet | Predicting the behavior of meningiomas based on histopathologic features alone has remained problematic.
This study retrospectively compared several... Abstract Background.—Predicting the behavior of meningiomas based on histopathologic features alone has remained problematic. Design.—This study... Predicting the behavior of meningiomas based on histopathologic features alone has remained problematic. This study retrospectively compared several... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 793 |
SubjectTerms | Adult Aged Aged, 80 and over Antigens, Nuclear Biomarkers, Tumor - metabolism Cell Division Cell Nucleolus - pathology Cell Nucleus - pathology Female Humans Immunohistochemistry Ki-67 Antigen Male Meningeal Neoplasms - metabolism Meningeal Neoplasms - pathology Meningioma - metabolism Meningioma - pathology Middle Aged Neoplasm Recurrence, Local - metabolism Neoplasm Recurrence, Local - pathology Nuclear Proteins - metabolism Predictive Value of Tests Retrospective Studies |
Title | Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas |
URI | https://www.ncbi.nlm.nih.gov/pubmed/10458826 https://www.proquest.com/docview/211969087/abstract/ |
Volume | 123 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4gJMaL8S2ipAevm9LSx3IyQEAwQoyRhItp9nkTEOr_d2ZbQA96aZNm2ybf7s7O7M73DcB9alIZtFWHYYRClJxOwHicKmZjITA8kCa2Lttimoxm0dM8nlfgccuFobTKrU10hlovFe2R-6REhpEcT30haRNA5f7D6pNR-Sg6Zi1raRxALQjRq8CBnc7TvfpuGO5K52F8ERccOvSUue9o-Gi-GSnFsdGwO3ke_16j_nA83QI0PIHj0nP0ukVXn0LFLM7gcFKejZ_Du1P8oArDhT3zrHGinRtPLLQ3GfdY4GGXO_65RyfVaCHw7q1px500mly7xXKxf_BhXD0jSiG6gNlw8NYfsbJ4AlO4wuTMtmxH8IgLGXasFLytVRBIq1IrY2U4F4mOtUhs4qIkIuyEgcHJrxItuVaifQlV_KW5Bi-RQqPnYHF62yghtRttI9HSkY2tFZrXgW3hylaFRkaGsQXBmxG8GcKbEbxZAW8dGltMs3LGbLJd_9bhqoD5x7eIThsmN_--14CjQlKB8r9uoZqvv8wdOgy5bLrBgFfeD5pQ6w2mL6_fl4rA8A |
link.rule.ids | 315,786,790,12083,12250,21416,27957,27958,31754,33301,33779,43345,43614,43840,74102,74371,74659 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JTwIxFG4UE_Vi3MV1Dl4bmK3TORkkkkEZTpBwMU3Xm4CA_9_3OgPoQU-TTGZJvrZvad_3PUIeM5upMNY5hQwFKTl5SHmaaepSKSE9UDZ1vtpiyIpx8jpJJ3VtzrIuq1zbRG-ozUzjHnkLlcggk-PZ0_yTYtMoPFytO2jskr0kBj-DRPHutsIjj6JNwzzIKtKKOQfxMW958j0YbYr6cLTodcpB_7dn-iPc9G6nd0yO6ngx6FQDfEJ27PSU7Jf1ifgZefc6H9hXuLJigbNeqnMZyKkJyv4zDQMYaM86D_B8GuwCXIMF7rOjMpN_bjqbbm98WN_FCAuHzsm49zLqFrRumUA1-JUVdW2XS55wqaLcKcljo8NQOZ05lWrLuWQmNZI55nMjpOlEoYUlr5lR3GgZX5AG_NJekYApaSBecLCoXcJQ48a4RLZN4lLnpOFNQtdwiXmljCEgo0B4BcIrAF6B8IoK3ia5WWMq6nWyFJtRbZLLCuYf30ISbcSu_33vgRwUo3IgBv3h2w05rEQVsALsljRWiy97ByHDSt37ifENixC9hw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTwIxEG58JMSL8S3iYw9eG9hl2-2eDCoEVIgxmnAxTZ83QQX_vzPdAnrQ0yabfSTfTOfRznxDyGXhCp22TUkhQ8GWnDKlghWGeqYUpAfaMR-qLUa8_5Lfjdk4UgrNYlnlwiYGQ22nBvfIm8hEBpmcKJo-VkU83vau3j8oDpDCg9Y4TWOdbBY5Z6Dgm9fd0ePTioE3y5bj8yDHYFUfHUTLohla8cGEU2SLo_1eZ_gw-O2n_gg-gxPq7ZDtGD0mnUrcu2TNTfZIbRjPx_fJa2D9wCnDlU1LvAvEnbNETWwyHFzTNAGxhx70BE-rwUrANfnEXXfkaQrPTaaT1Y03F2YaYRnRAXnpdZ9v-jQOUKAGvMyc-pYvlciF0lnptRJta9JUe1N4zYwTQnHLrOKeh0wJm3ay1IEBMNxqYY1qH5IN-KU7JgnXykL04GGJ-5wj4431uWrZ3DPvlRV1QhdwyfeKJ0NCfoHwSoRXArwS4ZUVvHXSWGAq46qZyaWM6-SogvnHt7ClNuMn_753QWqgFfJhMLpvkK2KYQHLwU7Jxvzzy51B_DDX51EzvgHrhcNf |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Histopathologic+features+and+MIB-1+labeling+indices+in+recurrent+and+nonrecurrent+meningiomas&rft.jtitle=Archives+of+pathology+%26+laboratory+medicine+%281976%29&rft.au=Abramovich%2C+C+M&rft.au=Prayson%2C+R+A&rft.date=1999-09-01&rft.issn=0003-9985&rft.volume=123&rft.issue=9&rft.spage=793&rft_id=info:doi/10.5858%2F1999-123-0793-HFAMLI&rft_id=info%3Apmid%2F10458826&rft.externalDocID=10458826 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-9985&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-9985&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-9985&client=summon |